Tag: Rocket Pharmaceuticals

  • Here’s Why Rocket Pharma Blasted 37% Higher

    Here’s Why Rocket Pharma Blasted 37% Higher

    Rocket Pharmaceuticals (RCKT) is blasting off. All after the company reached an “alignment” with the U.S. FDA over its mid-stage trial design for its Danon disease therapy, RP-A501, for which there are no US FDA-approved treatments. As noted by Barron’s, “The pharmaceutical company said Tuesday that it had reached an agreement with the FDA to…